The data shown below were compiled from readership statistics for 48 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Title |
Clinical use of cabozantinib in the treatment of advanced kidney cancer: efficacy, safety, and patient selection
|
---|---|
Published in |
OncoTargets and therapy, September 2016
|
DOI | 10.2147/ott.s97397 |
Pubmed ID | |
Authors |
Steven S Yu, David I Quinn, Tanya B Dorff |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 48 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 6 | 13% |
Researcher | 6 | 13% |
Student > Master | 5 | 10% |
Other | 4 | 8% |
Student > Ph. D. Student | 4 | 8% |
Other | 6 | 13% |
Unknown | 17 | 35% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 12 | 25% |
Biochemistry, Genetics and Molecular Biology | 8 | 17% |
Pharmacology, Toxicology and Pharmaceutical Science | 3 | 6% |
Agricultural and Biological Sciences | 3 | 6% |
Chemistry | 2 | 4% |
Other | 2 | 4% |
Unknown | 18 | 38% |
Attention Score in Context
This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 June 2024.
All research outputs
#5,446,994
of 25,374,647 outputs
Outputs from OncoTargets and therapy
#278
of 3,016 outputs
Outputs of similar age
#85,581
of 348,376 outputs
Outputs of similar age from OncoTargets and therapy
#9
of 86 outputs
Altmetric has tracked 25,374,647 research outputs across all sources so far. Compared to these this one has done well and is in the 75th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,016 research outputs from this source. They receive a mean Attention Score of 2.9. This one has done well, scoring higher than 89% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 348,376 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 73% of its contemporaries.
We're also able to compare this research output to 86 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 89% of its contemporaries.